Shortcuts

Detect cancer before clinical signs appear.

Introducing the IDEXX Nu.Q Canine Cancer Screen*, a simple and affordable cancer test that detects 7 common canine cancers at an overall detection rate of 49.8%.1

Cancer is the leading cause of death in adult dogs.2
Early detection gives you information and a fighting chance for effective treatment.

6 million

dogs in the U.S. are diagnosed with cancer each year.3

1 in 4

dogs in the U.S. will be diagnosed with
cancer in their lifetime.4

of pet owners globally consider their pet a part of their family.5

Now you can include the accessible and affordable IDEXX Nu.Q Canine Cancer Screen along with routine preventive care diagnostics.



The IDEXX Nu.Q Canine Cancer Screen detects 7 common canine cancers at an overall detection rate of 49.8%.*1

*At 97% specificity.

INCLUDING DETECTION RATES OF  • • • • • • • • • • • • • • • • • • • • • •
 

Hemangiosarcoma1

Lymphoma1

  • Minimally invasive (2–5 mL LTT blood specimen), affordable, and quick turnaround in 1–4 days
     
  • Detects circulating nucleosomes released by cancer cells using capture ELISA
     
  • Comprehensive support from IDEXX throughout your patient’s cancer diagnosis and treatment
     
  • Results in VetConnect PLUS for a holistic view of your patients’ health

Learn more about the IDEXX Nu.Q Canine Cancer Screen

Learn more about the IDEXX Nu.Q Canine Cancer Screen

IDEXX recommends a cancer screening test for all dogs over the age of 7 as well as younger dogs ages 4 and older with an increased risk of cancer in these breeds:

  • Labrador retriever
  • French bulldog
  • Golden retriever
  • German shepherd
  • Beagle
  • Rottweiler
  • Boxer
  • Pembroke Welsh corgi
  • Great Dane
  • Miniature schnauzer
  • Siberian husky
  • Bernese mountain dog
  • Mastiff
  • Irish wolfhound
  • Flat-coated retriever
  • Scottish wolfhound
Golden retriever in sunny field.
Cocker spaniel nose.

Order your IDEXX Nu.Q Canine Cancer Screen

Run alongside IDEXX Preventive Care Simple Start profiles and other wellness profiles.
IDEXX Nu.Q Canine Cancer Screen (test code 8993)

For cancer, this may include one or more of the following: 3-view chest radiographs, ultrasonography, computed tomography, MRI, or endoscopy. Appropriate specimens should be collected for pathology testing to achieve a definitive cancer diagnosis.

Follow these steps to ensure accuracy in specimen processing

1.
 

Patient must fast for a minimum of 4 hours prior to blood collection.

 

2.
 

Draw 2–5 mL of blood from peripheral vein.

3.
 

Immediately fill lavender-top tube (LTT; EDTA) with the blood specimen.

 

4.
 

Centrifuge the specimen within 60 minutes of collection (1,600 x g for 10 minutes).

5.
 

Transfer spun plasma specimen to a nonadditive tube (be careful to not disturb buffy coat).

6.
 

Store the specimen in a refrigerator, and ship it with a cold pack to IDEXX Reference Laboratories using your clinic’s routine submission method.
 

7.
 

View results in VetConnect PLUS alongside preventive care diagnostics for a holistic view of a patient’s health.

Medical resources
 

Clinical reference guide

IDEXX Nu.Q Screening Algorithm

On-demand Continuing Education: Oncology Imaging (IDEXX Telemedicine Consultants)

White dog gets pets from person.
Smiling woman with glasses talking to man.

An IDEXX team of experts dedicated to your success

Guiding you through each step of the cancer-care journey, our board-certified specialists offer direct live access and personalized guidance. 

Learn more about the team
Close up of smiling beagle face.

Enroll in IDEXX Preventive Care Simple Start today

Let us help you incorporate cancer screening into your preventive care guidelines simply and seamlessly.

Learn more about the Simple Start program

Speak with an IDEXX Veterinary Diagnostic Consultant to learn more.

Please complete the form below to get started.

* Nu.Q, Nucleosomics and Volition are trademarks of VolitionRx Limited and its subsidiaries. The Nu.Q Vet Cancer Test is supplied by Belgian Volition SRL.

References 

  1. Wilson-Robles HM, Bygott T, Kelly TK, et al. Evaluation of plasma nucleosome concentrations in dogs with a variety of common cancers and in healthy dogs. BMC Vet Res. 2022;18(1):329. doi:10.1186/s12917-022-03429-8 
  2. Fleming JM, Creevy KE, Promislow DE. Mortality in North American dogs from 1984 to 2004: an investigation into age-, size-, and breed-related causes of death. J Vet Intern Med. 2011;25(2):187–198. doi:10.1111/j.1939-1676.2011.0695.x 
  3. What is comparative oncology? National Cancer Institute Center for Cancer Research. Accessed December 22, 2022. ccr.cancer.gov/Comparative-Oncology-Program/pet-owners/what-is-comp-onc 
  4. What are the most common types of cancers in dogs? How many dogs typically get cancer? Veterinary Cancer Society; 2021. Accessed December 22, 2022. www.vetcancersociety.org/pet-owners/faqs 
  5. International survey of pet owners & veterinarians. Human Animal Bond Research Institute. January 16, 2022. Accessed December 22, 2022. www.habri.org/international-hab-survey